TELA

TELA Bio, Inc.

Healthcare
Medical - Devices
$43M market cap

Forecast run · Sep 16, 2026Upside rank 86 of 3,149

Model Signal

ForecastQ Daily Probabilities

67.6%

70.4%

82.8%

Analyst Consensus

Recommendation2.13/5 Buy

Last price$0.97

Price target$8.25

Implied move+750.5%

Analysts8

ForecastQ Portfolios

TELA is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.